NPPB and atrial fibrillation: Patient characteristics, including baseline plasma NT-proBNP level and left atrial diameter, did not differ between patients who had SR at follow-up and those in whom AF had recurred at follow-up (regardless of the outcome of cardioversion with flecainide; Table 2).